MODERATOR
:
PRESENTER
(S):
Laura Elizabeth Barrows, FSA, MAAA, FCA
Joel Shalowitz, M.D., MBA, FACP, Professor and Director, Health Industry Management Program, Kellogg School of Management - Northwestern University, Evanston, IL
Description
A number of brand name drugs have come off patent recently. What happens when a brand goes
generic? Panelists at this session will discuss the issue from a number of different perspectives,
including those of the brand pharmaceutical company, their competitors, the providers, the payers, and
the patients.
You'll better understand the various ways in which a single change can impact the various stakeholders in
the healthcare market and how to prepare your clients in advance.